ライフサイエンスコーパス: no evidence

1 No evidence of K-ras mutations was observed.

2 No evidence was found that selective deuteration affected eit

3 Among the patients with normal ALP and no evidence of cirrhosis, the 5-year incidence rate of PBC wa

4 Barcode sequences did not affect delivery, and no evidence of particle mixing was observed for tested partic

5 tment failure and our conclusions remain unchanged: we find no evidence for historical growth changes in our studied tree

6 t associations between VAX1 and human forms of CLP, we find no evidence of a direct role for this transcription factor in

7 We find no evidence that either MAC or PAC are associated with LTL in

8 This study of KPD-facilitated LDKTs found no evidence that long CIT is a concern for reduced graft or p

9 nic T2D case-control exome of 12,940 individuals that found no evidence of T2D risk association for rare frequency varian

10 We found no evidence for relative benefits of cognitive training with

11 d robust glycine-mediated tonic currents; however, we found no evidence for tonic GABAergic currents.

12 We found no evidence of differences between the treatment groups and c

13 We found no evidence of increased odds of serious infection in compari

14 We found no evidence that consumption of hen's egg starting at 4 to 6

15 We found no evidence that DeltaNT activation of NFAT is dependent on G

16 In summary, we found no evidence that ERG is an effector of SPOP mutation in human

17 In this study, we found no evidence that exposure to air pollution is a risk factor f

18 We found no evidence that gut microbe community composition was associ

19 INTERPRETATION: We found no evidence that means reduction through improved household p

20 Using a miR-H2-deficient mutant virus, we found no evidence that miR-H2 represses the expression of ICP0 or o

21 We found no evidence to support a clinically meaningful role of CYP2C1

22 rwent PET/CT imaging for the initial tumour staging and had no evidence of distant metastates.

23 At last follow-up, 87% of the surviving patients had no evidence of persistent or recurrent infections.

24 (89.6%) with and 68 of 160 (42.5%) without a breast pCR had no evidence of residual nodal disease (P < .01).

25 associated with lower first-phase insulin secretion but has no evidence for an effect on type 2 diabetes risk.

26 However, no evidence was identified to support a role of macrophage ef

27 1 h of exposure to 30,000 muatm was also assessed; however, no evidence of translocation was found.

28 INTERPRETATION: No evidence of benefit for ketamine was found although the sa

29 We conclude that there is no evidence for the existence of Drosophila courtship song rh

30 There is no evidence that increased foreclosure rates worsened glycemi

31 There is no evidence that, in clinical practice, lansoprazole can trea

32 ting causes of death may diminish the benefit, and there is no evidence to recommend screening in this group.

33 ith advanced disease compared with patients with limited or no evidence of disease, specifically physical function (41.1

34 The study therefore provides no evidence that intensive breeding has had negative effects

35 We report no evidence for neuroprotection by in vivo pretreatment with

36 cking by T2-weighted MRI as they are biocompatible and show no evidence of cytotoxic effects on hMSCs.

37 During late pregnancy, female mice show no evidence of chronic pain whatsoever.

38 The 3 individuals with complete ANGPTL3 deficiency showed no evidence of coronary atherosclerotic plaque.

39 zation reviewed available data and concluded that there was no evidence for the efficacy or effectiveness of a two-dose s

40 There was no evidence of a threshold in the exposure-response relations

41 with chronic abdominal pain or diarrhea, in whom there was no evidence of abnormal biomarkers typically associated with

42 There was no evidence of association between hemoglobin and brain or re

43 There was no evidence of improvement in complete response within 1 year

44 There was no evidence of VGX-6150 accumulation at the injection site or

45 There was no evidence that iCST has an effect on cognition or QoL for p

46 on average 10 days greater slaughter age than animals with no evidence of fasciolosis.

47 avir-treated subjects (56%) cleared virus in 2-18 days with no evidence of drug resistance, while 41 of 93 (44%) treated

48 CKD risk groups had multiplicative predictive effects, with no evidence of an interaction (p = 0.329 and p = 0.291 for CK

49 ients (macroalbuminuric, n = 121) to diabetic patients with no evidence of DN (normoalbuminuric, n = 118).

50 irst order in catalyst over all concentrations studied with no evidence of catalyst self-association.